Introduction
The Janus kinases (JAKs) are a family of non-receptor protein tyrosine kinases (PTKs) that consists of four mammalian isoforms: JAK1, JAK2, JAK3, and TYK2. The best established downstream effector of JAK is the signal transducer and activator of transcription (STAT) family. Seven STAT isoforms, named STAT1 to STAT4, STAT5A, STAT5B, and STAT6, have the nucleus, where they regulate the expression of many genes [1] [2] [3] . Indeed, a model of 4]. The Janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) axis upregulates choline acetyltransferase (ChAT) expression in presynapses (pre), leading to the increased release of acetylcholine (ACh), which binds to M1 mAChR on postsynapses (post) in the synaptic [4, 5] and a genetic model of aging [6] . Several studies of the function of M1 mAChR found 7] and that M1 mAChR 8]. In accordance, AG490 (a JAK inhibitor)-injected rats had memory impairment, and a mild reduction in the number of ChAT-positive neurons was observed in the medial septa of AG490-injected rats [4] . Minimal hepatic encephalopathy (MHE) has the characteristic of subtle changes in cognitive function [9 learning and memory [10] . Therefore, the JAK2/STAT3 pathway and downstream M1 mAChR Recent epidemiological and dietary interventional studies, both in humans and animals, population cognitive dysfunction [11 fruits, has been reported to attenuate behavioral alterations and cognitive impairment in kainic acid-induced epilepsy models [12] and 3-nitropropionic acid-induced Huntington models [13 14] , as well as colchicine-[15 16] and aluminium [17] -induced learning and memory impairment models. It has also been shown that naringin enhances memory activity in unstressed and stressed rats, probably by decreasing brain AChE activity [18] .
In our present study, we delineate the role of the JAK2/STAT3 signaling axis in MHEthe brains of MHE models on the activity of the JAK2/STAT3 axis. We also address the impact
Materials and Methods

MHE models and treatments
in Shanghai) weighing 220-250 g were used. Rats were housed under controlled conditions of temperature (24 ± 1°C) and light (12 h light starting at 07:00 am), and all experiments were carried out in accordance University regarding the care and use of animals for experimental procedures.
tests were obtained. Rats were then randomly divided into two groups: a control group (n=20) and a thioacetamide (TAA) group (n=30 
Behavioral tests 20].
The apparatus for the YM was made of gray plastic, with each arm 40 cm long, 12 cm high, 3 cm wide at the bottom and 10 cm wide at the top [20, 21] . The three arms were connected at an angle of 120°. Rats arm choices that differed from the previous two choices (successful choices) to the total choices during the 10 entries, such as 1-2-3-2-3-1-2-3-2-1, there were 5 successful choices out of 8 total choices (10 entries minus 2). 20, 22] . Two arms were st stay, the time from the closed arms.
20, 23].
2 drinking tube was inserted through a hole at the center of the alcove ceiling, with the tip of the tube placed apparatus and allowed to explore it freely for 3 min. Rats were omitted from the analysis when they could h. In the trial session, rats were again individually placed at the same corner of the apparatus and allowed to 
Determination of DA levels
Eicom Co., Kyoto, Japan), a Model 7125 sample injector (Rheodyne, Berkeley, CA), and a Model 100 electrochemical detector with a WE-3G carbon graphite working electrode (Eicom Co.), with the oxidation then through the electrochemical detector. Column temperature was maintained at 29 C with a temperaturecontrolled water bath. The mobile phase consisted of an 89:11 (v/v) mixture of methanol with sodium pressure. All chromatograms were recorded and the areas under the peaks of the respective analytes were Dou le-la eled luorescent staining for tissues and luorescent staining for C s For tissues: or 4% formaldehyde was blocked with 0.03% H 2 2 if appropriate.
For C s:
min at room temperature. Sections were blocked with PBS containing 5% normal goat serum for 1 h at room temperature. Sections were then incubated overnight at 4°C with diluted primary antibodies to the following targets: mAChR, MAP2 (Abcam), 1:250. Binding of primary antibodies was detected by incubating the sections for 30 min with Alexa Fluor 488 (green)/Alexa Fluor 594 (red) conjugated secondary antibody.
Immunoblotting (IB)
For ChAT/M1 mAChR assays, the cerebral cortex tissues or PCNs were harvested in a lysis buffer (50 in the above lysis buffer with the addition of phosphatase inhibitor (1 mM Na 3 4 ).
The total amount of protein was determined by bicinchoninic acid protein assay (Amresco). Samples blocked by incubation in 5% non-fat dry milk dissolved in TBS-T (150 mM NaCl, 50 mM Tris, 0.05% Tween 20) . Following transfer, proteins were probed using a primary antibody: p-JAK 2, JAK 2, p-STAT 3, ChAT, p44/ peroxidase-conjugated anti-rabbit secondary antibody was used. After extensive washing, protein bands 
Statistical analysis
Results
Memory impairment and elevation of intracranial DA levels in MHE models
HE and Masson staining in the livers of TAA-treated rats showed bridging or septal Fig. 1a and b ), These observations suggested that the liver . In EPM, 18 TAAarms and less in the closed arms compared with controls (Fig. 1e) . In WFT, TAA treatment rats out of 30 was detected as compared with controls (Fig. 1f) . Accordingly, there were 24 TAA-treated rats with at least one abnormal behavioral test and 6 TAA-treated rats without any abnormal behavior, suggesting 24 hepatic cirrhosis rats with MHE/HE and 6 hepatic in 6 TAA-treated rats (Fig. 1g) , suggesting there were 18 MHE rats and 6 HE rats.
indicated alteration of BBB permeability induced by liver cirrhosis. Cerebral DA overload causes inactivation of the JAK2/STAT3 axis models [4], so we examined whether memory impairment in MHE rats is associated with whether changes in expression of JAK2/STAT3 exist in the cerebral cortexes of MHE rats rats displayed a lower number of p-JAK2/p-STAT3-positive neurons than vehicle rats based on double IF staining ( Fig. 3c and d) .
DA treatment causes memory impairment
neuronal marker) confirmed the downregulation of p-JAK2/p-STAT3 in neurons of vehicles ( Fig. 3h and i) . Thus, p-JAK2/p-STAT3 levels in the nuclei of cortical neurons were cultured neurons in vitro inactivation of JAK2/STAT3.
Ding et al.: Naringin Against MHE via JAK2/STAT3
Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry rats, which was lower than that of normal rats, recovered to normal levels after treatment with naringin (Fig. 5a ). Naringin treatment also conversely restored the number of cortical ChAT/M1 mAChRpositive neurons in MHE rats ( Fig. 5c and d) . IB analysis and double IF staining also revealed that ChAT and M1 mAChR levels were reduced in the cerebral cortex 
Desensitization of the M1 mAChR in MHE by DA
[4 inhibiting the JAK2/STAT3 axis. As expected, p-ERK levels were substantially increased by i.p.
CCh-induced p-ERK in PCNs (Fig. 7a) . Pretreatment with tacrine, a cholinesterase inhibitor, modestly increased CCh-induced p-ERK, presumably because of the inhibition of endogenous p-ERK in PCNs (Fig. 7c) . These results suggest that M1 mAChR-mediated signals require the activation of STAT3 and M1 mAChR in inducing ERK phosphorylation.
To examine the effect of naringin on the activity of M1 mAChR, we treated CCh-injected rats with AG490 and found that CCh-induced p-ERK was inhibited by AG490 (Fig. 7e) . AG490-induced suppression of CCh-evoked p-ERK in the cortical lysates was eliminated by (Fig. 7g) , recovered to normal levels after treatment with naringin. We also found that the ERK phosphorylation induced by CCh was inhibited in MHE rats, and naringin reversed the inhibition of CCh-induced p-ERK in MHE rats to close to the normal level (Fig. 7i) . All the receptor at a CaMKII -dependent site [14 [25] . Additionally, our study observed that the JAK2/STAT3 axis is necessary for the pharmacological effect of naringin on MHE. Therefore, we assume that the activation of the JAK2/STAT3 axis by naringin may be stimulated by increasing phosphorylation of upstream in MHE models. Considering that leukemia inhibitory factor and ciliary neurotrophic factor, both of which can activate STAT3, are reported to have roles in the expression of ChAT and VAChT [26, 27] , STAT3 activation is one of the key transcriptional factors for cholinergic neurons. We examined whether STAT3-mediated transcriptional regulation of genes related to in vitro experiments revealed that neurons [28 endogenous ChAT expression in the medial septa may be dependent on the JAK2/STAT3 axis [8] .
To examine how the function of M1 mAChR is regulated by the JAK2/STAT3 axis, axis in MHE models.
learning. Some studies showed that learning and retention of memory, required for optimal 29, 30]. However, some studies found that dopamine impairs or have no effect on, stimulus-response learning and working memory in Parkinsonism or MHE [31] [32] [33] 
Conclusion
STAT3 signaling axis and downregulation of downstream M1 mAChR causes memory in MHE but also a novel target in MHE therapy. Notably, the functional deterioration in the JAK2/STAT3 axis was reversed, concomitantly with memory improvement, by naringinmemory impairment will be further investigated.
